Dr. Paul Richardson led a study that found an experimental
immune-boosting drug shows promise in fighting the blood cancer multiple
Tom Brokaw discussed his life after being diagnosed with multiple myeloma and cites Dr. Ken Anderson for being both a respected clinician and friend.
Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.
Former “NBC Nightly News” anchor Tom Brokaw, who was diagnosed with multiple myeloma in 2013, toured Dana-Farber and spoke at the Visiting Committee dinner.
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Tags: chemotherapy, MultipleMyeloma
Tags: BasicResearch, MultipleMyeloma
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: